KR101951203B1 - A composition for preventing or treating respiratory cancers comprising herbal ingredients - Google Patents
A composition for preventing or treating respiratory cancers comprising herbal ingredients Download PDFInfo
- Publication number
- KR101951203B1 KR101951203B1 KR1020150135248A KR20150135248A KR101951203B1 KR 101951203 B1 KR101951203 B1 KR 101951203B1 KR 1020150135248 A KR1020150135248 A KR 1020150135248A KR 20150135248 A KR20150135248 A KR 20150135248A KR 101951203 B1 KR101951203 B1 KR 101951203B1
- Authority
- KR
- South Korea
- Prior art keywords
- composition
- weight
- chinese cabbage
- ginseng
- cabbage
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000000203 mixture Substances 0.000 claims abstract description 41
- 206010028980 Neoplasm Diseases 0.000 claims abstract description 28
- 201000011510 cancer Diseases 0.000 claims abstract description 26
- 230000000241 respiratory effect Effects 0.000 claims abstract description 21
- 239000004480 active ingredient Substances 0.000 claims abstract description 11
- 235000008434 ginseng Nutrition 0.000 claims description 31
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 29
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 29
- 241000411851 herbal medicine Species 0.000 claims description 16
- 239000004615 ingredient Substances 0.000 claims description 13
- 241000190633 Cordyceps Species 0.000 claims description 9
- 230000001093 anti-cancer Effects 0.000 claims description 9
- 235000013376 functional food Nutrition 0.000 claims description 6
- 230000036541 health Effects 0.000 claims description 6
- 244000299790 Rheum rhabarbarum Species 0.000 claims description 5
- 235000009411 Rheum rhabarbarum Nutrition 0.000 claims description 5
- 241000283707 Capra Species 0.000 claims description 4
- 244000018436 Coriandrum sativum Species 0.000 claims description 3
- 235000002787 Coriandrum sativum Nutrition 0.000 claims description 3
- 241000238557 Decapoda Species 0.000 claims description 3
- 240000004670 Glycyrrhiza echinata Species 0.000 claims description 3
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 claims description 3
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims description 3
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 claims description 3
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 claims description 3
- 244000061456 Solanum tuberosum Species 0.000 claims description 3
- 235000002595 Solanum tuberosum Nutrition 0.000 claims description 3
- 235000011684 Sorghum saccharatum Nutrition 0.000 claims description 3
- 240000008042 Zea mays Species 0.000 claims description 3
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 3
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 3
- 244000273928 Zingiber officinale Species 0.000 claims description 3
- 235000006886 Zingiber officinale Nutrition 0.000 claims description 3
- 235000005822 corn Nutrition 0.000 claims description 3
- 235000008397 ginger Nutrition 0.000 claims description 3
- 238000002347 injection Methods 0.000 claims description 3
- 239000007924 injection Substances 0.000 claims description 3
- 229940010454 licorice Drugs 0.000 claims description 3
- 229910052573 porcelain Inorganic materials 0.000 claims description 3
- 210000004207 dermis Anatomy 0.000 claims description 2
- 238000000034 method Methods 0.000 claims description 2
- 210000002345 respiratory system Anatomy 0.000 claims description 2
- 235000010149 Brassica rapa subsp chinensis Nutrition 0.000 claims 12
- 235000000536 Brassica rapa subsp pekinensis Nutrition 0.000 claims 12
- 241000499436 Brassica rapa subsp. pekinensis Species 0.000 claims 12
- 241000208340 Araliaceae Species 0.000 claims 6
- 240000007124 Brassica oleracea Species 0.000 claims 5
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 claims 5
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 claims 5
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 claims 5
- 230000002745 absorbent Effects 0.000 claims 3
- 239000002250 absorbent Substances 0.000 claims 3
- 206010013647 Drowning Diseases 0.000 claims 1
- 244000017020 Ipomoea batatas Species 0.000 claims 1
- 235000002678 Ipomoea batatas Nutrition 0.000 claims 1
- 235000006679 Mentha X verticillata Nutrition 0.000 claims 1
- 235000002899 Mentha suaveolens Nutrition 0.000 claims 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 claims 1
- 241000245165 Rhododendron ponticum Species 0.000 claims 1
- 240000006394 Sorghum bicolor Species 0.000 claims 1
- 244000269722 Thea sinensis Species 0.000 claims 1
- 235000013372 meat Nutrition 0.000 claims 1
- 229940107131 ginseng root Drugs 0.000 abstract description 6
- 239000008194 pharmaceutical composition Substances 0.000 abstract description 4
- 230000002265 prevention Effects 0.000 abstract description 4
- 240000004371 Panax ginseng Species 0.000 description 25
- 239000000284 extract Substances 0.000 description 18
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 17
- 208000020816 lung neoplasm Diseases 0.000 description 17
- 201000005202 lung cancer Diseases 0.000 description 16
- 210000004027 cell Anatomy 0.000 description 13
- 230000000694 effects Effects 0.000 description 13
- 239000003814 drug Substances 0.000 description 9
- 230000009471 action Effects 0.000 description 8
- 229940079593 drug Drugs 0.000 description 7
- 238000010521 absorption reaction Methods 0.000 description 6
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
- 244000274050 Platycodon grandiflorum Species 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 210000004072 lung Anatomy 0.000 description 5
- 230000000144 pharmacologic effect Effects 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 241000208422 Rhododendron Species 0.000 description 4
- 231100000263 cytotoxicity test Toxicity 0.000 description 4
- 230000006872 improvement Effects 0.000 description 4
- 230000004083 survival effect Effects 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 235000011511 Diospyros Nutrition 0.000 description 3
- 244000236655 Diospyros kaki Species 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 241000238631 Hexapoda Species 0.000 description 3
- 235000002789 Panax ginseng Nutrition 0.000 description 3
- 235000006751 Platycodon Nutrition 0.000 description 3
- 206010036790 Productive cough Diseases 0.000 description 3
- 230000000845 anti-microbial effect Effects 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 229930014626 natural product Natural products 0.000 description 3
- 229930189914 platycodon Natural products 0.000 description 3
- 230000000391 smoking effect Effects 0.000 description 3
- 208000024794 sputum Diseases 0.000 description 3
- 210000003802 sputum Anatomy 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- 241000703121 Campanula rotundifolia Species 0.000 description 2
- 240000004385 Centaurea cyanus Species 0.000 description 2
- 235000005940 Centaurea cyanus Nutrition 0.000 description 2
- 241000723346 Cinnamomum camphora Species 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 2
- 244000246386 Mentha pulegium Species 0.000 description 2
- 235000016257 Mentha pulegium Nutrition 0.000 description 2
- 235000004357 Mentha x piperita Nutrition 0.000 description 2
- 235000006753 Platycodon grandiflorum Nutrition 0.000 description 2
- 240000003768 Solanum lycopersicum Species 0.000 description 2
- 240000003829 Sorghum propinquum Species 0.000 description 2
- 235000021307 Triticum Nutrition 0.000 description 2
- 244000098338 Triticum aestivum Species 0.000 description 2
- YURJSTAIMNSZAE-UHFFFAOYSA-N UNPD89172 Natural products C1CC(C2(CC(C3C(C)(C)C(O)CCC3(C)C2CC2O)OC3C(C(O)C(O)C(CO)O3)O)C)(C)C2C1C(C)(CCC=C(C)C)OC1OC(CO)C(O)C(O)C1O YURJSTAIMNSZAE-UHFFFAOYSA-N 0.000 description 2
- 208000007502 anemia Diseases 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 239000002246 antineoplastic agent Substances 0.000 description 2
- 229940041181 antineoplastic drug Drugs 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 210000000621 bronchi Anatomy 0.000 description 2
- 244000309464 bull Species 0.000 description 2
- 229960000846 camphor Drugs 0.000 description 2
- 229930008380 camphor Natural products 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 208000037976 chronic inflammation Diseases 0.000 description 2
- 230000006020 chronic inflammation Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 229930182494 ginsenoside Natural products 0.000 description 2
- YURJSTAIMNSZAE-HHNZYBFYSA-N ginsenoside Rg1 Chemical compound O([C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(C[C@@H]([C@H]4C(C)(C)[C@@H](O)CC[C@]4(C)[C@H]3C[C@H]2O)O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)C)(C)CC1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O YURJSTAIMNSZAE-HHNZYBFYSA-N 0.000 description 2
- CBEHEBUBNAGGKC-UHFFFAOYSA-N ginsenoside Rg1 Natural products CC(=CCCC(C)(OC1OC(CO)C(O)C(O)C1O)C2CCC3(C)C2C(O)CC4C5(C)CCC(O)C(C)(C)C5CC(OC6OC(CO)C(O)C(O)C6O)C34C)C CBEHEBUBNAGGKC-UHFFFAOYSA-N 0.000 description 2
- 235000012907 honey Nutrition 0.000 description 2
- 235000001050 hortel pimenta Nutrition 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000003908 liver function Effects 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 208000002154 non-small cell lung carcinoma Diseases 0.000 description 2
- 230000001766 physiological effect Effects 0.000 description 2
- 208000000649 small cell carcinoma Diseases 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000010902 straw Substances 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 235000019640 taste Nutrition 0.000 description 2
- 210000003437 trachea Anatomy 0.000 description 2
- 208000029729 tumor suppressor gene on chromosome 11 Diseases 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 230000037303 wrinkles Effects 0.000 description 2
- FBFMBWCLBGQEBU-RXMALORBSA-N (2s,3r,4s,5s,6r)-2-[(2r,3r,4s,5s,6r)-2-[[(3s,5r,6s,8r,9r,10r,12r,13r,14r,17s)-3,12-dihydroxy-4,4,8,10,14-pentamethyl-17-[(2s)-6-methyl-2-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhept-5-en-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecah Chemical compound O([C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(C[C@@H]([C@H]4C(C)(C)[C@@H](O)CC[C@]4(C)[C@H]3C[C@H]2O)O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)C)(C)CC1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O FBFMBWCLBGQEBU-RXMALORBSA-N 0.000 description 1
- LEBVLXFERQHONN-UHFFFAOYSA-N 1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide Chemical compound CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C LEBVLXFERQHONN-UHFFFAOYSA-N 0.000 description 1
- CNHZRRBWLMSLDX-WNHLAMKZSA-N 2''O-acetylplatycodin D Chemical compound O([C@H]1[C@@H](O)C[C@]2(C)[C@H]3CC=C4[C@@H]5CC(C)(C)CC[C@@]5([C@@H](C[C@@]4(C)[C@]3(C)CC[C@H]2C1(CO)CO)O)C(=O)O[C@@H]1OC[C@H](O)[C@H](O)[C@H]1O[C@@H]1O[C@H]([C@@H]([C@@H](O)[C@H]1OC(C)=O)O[C@H]1[C@@H]([C@@H](O[C@H]2[C@@H]([C@@](O)(CO)CO2)O)[C@H](O)CO1)O)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O CNHZRRBWLMSLDX-WNHLAMKZSA-N 0.000 description 1
- FBFMBWCLBGQEBU-GYMUUCMZSA-N 20-gluco-ginsenoside-Rf Natural products O([C@](CC/C=C(\C)/C)(C)[C@@H]1[C@H]2[C@H](O)C[C@H]3[C@](C)([C@]2(C)CC1)C[C@H](O[C@@H]1[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O2)[C@@H](O)[C@H](O)[C@@H](CO)O1)[C@H]1C(C)(C)[C@@H](O)CC[C@]31C)[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 FBFMBWCLBGQEBU-GYMUUCMZSA-N 0.000 description 1
- SDKXNUPDGQJUHA-ACRKBEDHSA-N 3''O-acetylplatycodin D Chemical compound O([C@H]1[C@@H](O)C[C@]2(C)[C@H]3CC=C4[C@@H]5CC(C)(C)CC[C@@]5([C@@H](C[C@@]4(C)[C@]3(C)CC[C@H]2C1(CO)CO)O)C(=O)O[C@@H]1OC[C@H](O)[C@H](O)[C@H]1O[C@@H]1O[C@H]([C@@H]([C@@H](OC(C)=O)[C@H]1O)O[C@H]1[C@@H]([C@@H](O[C@H]2[C@@H]([C@@](O)(CO)CO2)O)[C@H](O)CO1)O)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SDKXNUPDGQJUHA-ACRKBEDHSA-N 0.000 description 1
- PXQNZQURQNZGKZ-UHFFFAOYSA-N 3-O-beta-Laminaribiosyl-platycodin-D(2) Natural products OC1C(O)C(OC2C(C(OC3C(C(O)(CO)CO3)O)C(O)CO2)O)C(C)OC1OC1C(O)C(O)COC1OC(=O)C1(C(CC2(C)C3(C)CCC4C5(CO)CO)O)CCC(C)(C)CC1C2=CCC3C4(C)CC(O)C5OC(C1O)OC(CO)C(O)C1OC1OC(CO)C(O)C(O)C1O PXQNZQURQNZGKZ-UHFFFAOYSA-N 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- APKFDSVGJQXUKY-KKGHZKTASA-N Amphotericin-B Natural products O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1C=CC=CC=CC=CC=CC=CC=C[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-KKGHZKTASA-N 0.000 description 1
- 241000272814 Anser sp. Species 0.000 description 1
- 241001530392 Aphos Species 0.000 description 1
- 241000193738 Bacillus anthracis Species 0.000 description 1
- 240000001548 Camellia japonica Species 0.000 description 1
- 241000208671 Campanulaceae Species 0.000 description 1
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 1
- 201000009030 Carcinoma Diseases 0.000 description 1
- 240000004307 Citrus medica Species 0.000 description 1
- 241001391944 Commicarpus scandens Species 0.000 description 1
- 206010010305 Confusional state Diseases 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- 241001264174 Cordyceps militaris Species 0.000 description 1
- 206010065420 Coronary artery dilatation Diseases 0.000 description 1
- 208000019505 Deglutition disease Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 235000011201 Ginkgo Nutrition 0.000 description 1
- 235000008100 Ginkgo biloba Nutrition 0.000 description 1
- 244000194101 Ginkgo biloba Species 0.000 description 1
- UFNDONGOJKNAES-UHFFFAOYSA-N Ginsenoside Rb1 Natural products CC(=CCCC(C)(OC1OC(COC2OC(CO)C(O)C(O)C2O)C(O)C(O)C1O)C3CCC4(C)C3C(O)CC5C6(C)CCC(OC7OC(CO)C(O)C(O)C7OC8OC(CO)C(O)C(O)C8O)C(C)(C)C6CC(O)C45C)C UFNDONGOJKNAES-UHFFFAOYSA-N 0.000 description 1
- HYPFYJBWSTXDAS-UHFFFAOYSA-N Ginsenoside Rd Natural products CC(=CCCC(C)(OC1OC(CO)C(O)C(O)C1O)C2CCC3(C)C4CCC5C(C)(C)C(CCC5(C)C4CC(O)C23C)OC6OC(CO)C(O)C(O)C6OC7OC(CO)C(O)C(O)C7O)C HYPFYJBWSTXDAS-UHFFFAOYSA-N 0.000 description 1
- 241001316290 Gypsophila Species 0.000 description 1
- 208000032969 Hemorrhagic Septicemia Diseases 0.000 description 1
- 241000282596 Hylobatidae Species 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 244000116484 Inula helenium Species 0.000 description 1
- 235000002598 Inula helenium Nutrition 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 241000695810 Lycoris x chejuensis Species 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- 235000008708 Morus alba Nutrition 0.000 description 1
- 241000187479 Mycobacterium tuberculosis Species 0.000 description 1
- 240000001307 Myosotis scorpioides Species 0.000 description 1
- 206010073310 Occupational exposures Diseases 0.000 description 1
- 241001248610 Ophiocordyceps sinensis Species 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 241000237502 Ostreidae Species 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 208000014645 Pasteurella hemorrhagic septicemia Diseases 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- XHKCYIRZWRRXNG-UHFFFAOYSA-N Platycodin D3 Natural products OC1C(O)C(OC2C(C(OC3C(C(O)(CO)CO3)O)C(O)CO2)O)C(C)OC1OC1C(O)C(O)COC1OC(=O)C1(C(CC2(C)C3(C)CCC4C5(CO)CO)O)CCC(C)(C)CC1C2=CCC3C4(C)CC(O)C5OC(C(C(O)C1O)O)OC1COC1OC(CO)C(O)C(O)C1O XHKCYIRZWRRXNG-UHFFFAOYSA-N 0.000 description 1
- 239000012980 RPMI-1640 medium Substances 0.000 description 1
- 241000269435 Rana <genus> Species 0.000 description 1
- 244000088415 Raphanus sativus Species 0.000 description 1
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 description 1
- 241000269821 Scombridae Species 0.000 description 1
- 235000003434 Sesamum indicum Nutrition 0.000 description 1
- 244000040738 Sesamum orientale Species 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 206010041067 Small cell lung cancer Diseases 0.000 description 1
- 235000009337 Spinacia oleracea Nutrition 0.000 description 1
- 244000300264 Spinacia oleracea Species 0.000 description 1
- 241000193998 Streptococcus pneumoniae Species 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 241000219995 Wisteria Species 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 208000009956 adenocarcinoma Diseases 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- APKFDSVGJQXUKY-INPOYWNPSA-N amphotericin B Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-INPOYWNPSA-N 0.000 description 1
- 229960003942 amphotericin b Drugs 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001078 anti-cholinergic effect Effects 0.000 description 1
- 230000002082 anti-convulsion Effects 0.000 description 1
- 230000003254 anti-foaming effect Effects 0.000 description 1
- 230000000702 anti-platelet effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000002180 anti-stress Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 210000003056 antler Anatomy 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 229940065181 bacillus anthracis Drugs 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 230000003925 brain function Effects 0.000 description 1
- 230000007883 bronchodilation Effects 0.000 description 1
- 229960003150 bupivacaine Drugs 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 231100000315 carcinogenic Toxicity 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 229940112822 chewing gum Drugs 0.000 description 1
- 235000015218 chewing gum Nutrition 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 229910052956 cinnabar Inorganic materials 0.000 description 1
- 235000018597 common camellia Nutrition 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 206010013663 drug dependence Diseases 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000003979 eosinophil Anatomy 0.000 description 1
- 210000003238 esophagus Anatomy 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 229940089161 ginsenoside Drugs 0.000 description 1
- GZYPWOGIYAIIPV-JBDTYSNRSA-N ginsenoside Rb1 Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)O[C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(CC[C@H]4C(C)(C)[C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O)CC[C@]4(C)[C@H]3C[C@H]2O)C)(C)CC1)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O GZYPWOGIYAIIPV-JBDTYSNRSA-N 0.000 description 1
- TXEWRVNOAJOINC-UHFFFAOYSA-N ginsenoside Rb2 Natural products CC(=CCCC(OC1OC(COC2OCC(O)C(O)C2O)C(O)C(O)C1O)C3CCC4(C)C3C(O)CC5C6(C)CCC(OC7OC(CO)C(O)C(O)C7OC8OC(CO)C(O)C(O)C8O)C(C)(C)C6CCC45C)C TXEWRVNOAJOINC-UHFFFAOYSA-N 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 239000012676 herbal extract Substances 0.000 description 1
- 230000002363 herbicidal effect Effects 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000036543 hypotension Effects 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 208000003849 large cell carcinoma Diseases 0.000 description 1
- 235000015122 lemonade Nutrition 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 201000005296 lung carcinoma Diseases 0.000 description 1
- 230000005980 lung dysfunction Effects 0.000 description 1
- 201000005243 lung squamous cell carcinoma Diseases 0.000 description 1
- 230000001926 lymphatic effect Effects 0.000 description 1
- 210000004324 lymphatic system Anatomy 0.000 description 1
- 235000020640 mackerel Nutrition 0.000 description 1
- 230000036210 malignancy Effects 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 231100000544 menstrual irregularity Toxicity 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 231100000675 occupational exposure Toxicity 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 201000005737 orchitis Diseases 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 235000020636 oyster Nutrition 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 229940027779 persimmon extract Drugs 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- IVDSKBGNLNNRFN-UHFFFAOYSA-N platycodin A Natural products CC1OC(OC2C(O)C(O)COC2OC(=O)C34CCC(C)(C)CC3C5=CCC6C7(C)CC(O)C(OC8CC(CO)C(O)C(O)C8O)C(CO)(CO)C7CCC6(C)C5(C)CC4O)C(OC(=O)C)C(O)C1OC9OCC(O)C(OC%10OCC(O)(CO)C%10O)C9O IVDSKBGNLNNRFN-UHFFFAOYSA-N 0.000 description 1
- CGAIRBPQYHFIOM-UHFFFAOYSA-N platycodin C Natural products CC1OC(OC2C(O)C(O)COC2OC(=O)C34CCC(C)(C)CC3C5=CCC6C7(C)CC(O)C(OC8CC(CO)C(O)C(O)C8O)C(CO)(CO)C7CCC6(C)C5(C)CC4O)C(O)C(OC(=O)C)C1OC9OCC(O)C(OC%10OCC(O)(CO)C%10O)C9O CGAIRBPQYHFIOM-UHFFFAOYSA-N 0.000 description 1
- GWBIYORWNUYYMZ-UHFFFAOYSA-N platycodin D Natural products CC1OC(OC2C(O)C(O)COC2OC(=O)C34CCC(C)(C)CC3C5=CCC6C7(C)CC(O)C(OC8CC(CO)C(O)C(O)C8O)C(CO)(CO)C7CCC6(C)C5(C)CC4O)C(O)C(O)C1OC9OCC(O)C(OC%10OCC(O)(CO)C%10O)C9O GWBIYORWNUYYMZ-UHFFFAOYSA-N 0.000 description 1
- CYBWUNOAQPMRBA-NDTOZIJESA-N platycodin D Chemical compound O([C@H]1[C@@H](O)C[C@]2(C)[C@H]3CC=C4[C@@H]5CC(C)(C)CC[C@@]5([C@@H](C[C@@]4(C)[C@]3(C)CC[C@H]2C1(CO)CO)O)C(=O)O[C@@H]1OC[C@H](O)[C@H](O)[C@H]1O[C@@H]1O[C@H]([C@@H]([C@@H](O)[C@H]1O)O[C@H]1[C@@H]([C@@H](O[C@H]2[C@@H]([C@@](O)(CO)CO2)O)[C@H](O)CO1)O)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O CYBWUNOAQPMRBA-NDTOZIJESA-N 0.000 description 1
- PXQNZQURQNZGKZ-MXNHKPIDSA-N platycodin D2 Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O)O[C@H]1[C@@H](O)C[C@]2(C)[C@H]3CC=C4[C@@H]5CC(C)(C)CC[C@@]5([C@@H](C[C@@]4(C)[C@]3(C)CC[C@H]2C1(CO)CO)O)C(=O)O[C@@H]1OC[C@H](O)[C@H](O)[C@H]1O[C@@H]1O[C@H]([C@@H]([C@@H](O)[C@H]1O)O[C@H]1[C@@H]([C@@H](O[C@H]2[C@@H]([C@@](O)(CO)CO2)O)[C@H](O)CO1)O)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O PXQNZQURQNZGKZ-MXNHKPIDSA-N 0.000 description 1
- XHKCYIRZWRRXNG-COMVGSAYSA-N platycodin D3 Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)O[C@H]1[C@@H](O)C[C@]2(C)[C@H]3CC=C4[C@@H]5CC(C)(C)CC[C@@]5([C@@H](C[C@@]4(C)[C@]3(C)CC[C@H]2C1(CO)CO)O)C(=O)O[C@@H]1OC[C@H](O)[C@H](O)[C@H]1O[C@@H]1O[C@H]([C@@H]([C@@H](O)[C@H]1O)O[C@H]1[C@@H]([C@@H](O[C@H]2[C@@H]([C@@](O)(CO)CO2)O)[C@H](O)CO1)O)C)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O XHKCYIRZWRRXNG-COMVGSAYSA-N 0.000 description 1
- 230000027517 positive regulation of hormone secretion Effects 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000002271 resection Methods 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 231100000046 skin rash Toxicity 0.000 description 1
- 208000000587 small cell lung carcinoma Diseases 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 206010041823 squamous cell carcinoma Diseases 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 229940031000 streptococcus pneumoniae Drugs 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 208000011117 substance-related disease Diseases 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 210000001215 vagina Anatomy 0.000 description 1
- UOJAEODBOCLNBU-UHFFFAOYSA-N vinaginsenoside R4 Natural products C1CC(C2(CC(O)C3C(C)(C)C(OC4C(C(O)C(O)C(CO)O4)OC4C(C(O)C(O)C(CO)O4)O)CCC3(C)C2CC2O)C)(C)C2C1C(C)(CCC=C(C)C)OC1OC(CO)C(O)C(O)C1O UOJAEODBOCLNBU-UHFFFAOYSA-N 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/289—Vladimiria
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
- A61K36/066—Clavicipitaceae
- A61K36/068—Cordyceps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/308—Foods, ingredients or supplements having a functional effect on health having an effect on cancer prevention
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/314—Foods, ingredients or supplements having a functional effect on health having an effect on lung or respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Mycology (AREA)
- Botany (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
Abstract
본 발명은 생약 성분을 포함하는 호흡기암 예방 또는 치료용 약학적 조성물에 관한 것으로, 상세하게는 목향, 단삼, 산양산삼 또는 현삼, 동충하초 및 장생도라지 성분을 유효성분으로 포함하여, 호흡기암에 대한 항암효과가 탁월한 호흡기암 예방 또는 치료용 조성물에 관한 것이다.The present invention relates to a pharmaceutical composition for the prevention or treatment of respiratory cancer comprising a herbal composition, and more particularly to a pharmaceutical composition for preventing or treating respiratory cancer, which comprises as an active ingredient a herbal composition, a herbarium ginseng root, The present invention relates to a composition for preventing or treating respiratory cancer.
Description
본 발명은 생약 성분을 포함하는 호흡기암 예방 또는 치료용 약학적 조성물에 관한 것으로, 상세하게는 목향, 단삼, 산양산삼 또는 현삼, 동충하초 및 장생도라지 성분을 유효성분으로 포함하여, 호흡기암에 대한 항암효과가 탁월한 호흡기암 예방 또는 치료용 조성물에 관한 것이다.The present invention relates to a pharmaceutical composition for the prevention or treatment of respiratory cancer comprising a herbal composition, and more particularly to a pharmaceutical composition for preventing or treating respiratory cancer, which comprises as an active ingredient a herbal composition, a herbarium ginseng root, The present invention relates to a composition for preventing or treating respiratory cancer.
폐암(lung cancer)은 국내에서 3번째로 흔하게 발생하는 암으로, 최근 암이나 간암에 의한 사망률은 줄고 있는 반면, 폐암에 의한 사망률은 급격히 증가 하고 있다. 폐암의 5년 생존율은 단지 13%로서 췌장, 간, 그리고 식도에 발생한 암을 제외한 다른 어떤 부위의 암보다 예후가 나쁘다고 알려져 있다.Lung cancer is the third most common cancer in Korea. Recently, mortality from cancer and liver cancer has been reduced, while mortality from lung cancer has increased sharply. The 5-year survival rate of lung cancer is only 13%, which is known to be worse than other cancers of the pancreas, liver, and esophagus except cancer.
폐암은 40~70세에 자주 발생하며, 드물게 40세 이전에 발생하기도 한다. 남녀의 발생 비는 1960년대의 7:1에 비해 1980년대 이후 여성의 비율이 높아지고 있다. 이는 여성 흡연율의 증가에 기인하는 것으로 분석되고 있다. Lung cancer is common in people aged 40 to 70, and rarely occurs before
폐암의 중요한 위험인자는 흡연과 기타 발암성물질에 대한 직업적 노출인데, 특히 기관(trachea) 및 기관지(bronchus)에 생긴 암은 90% 이상이 흡연으로부터 초래되는 것으로 보고되어 있다. 폐암은 암세포의 현미경학적 세포형태에 따라 크게 비소세포 폐암(non-small cell carcinoma)과 소세포 폐암(small cell carcinoma)으로 구분하는데 비소세포 폐암은 전체 폐암의 약 80%를 차지하며 편평상피세포암(squamous cell carcinoma), 선암(adenocarcinoma) 및 대세포암(large-cell carcinoma)의 3가지 아형이 있다.The major risk factors for lung cancer are occupational exposure to smoking and other carcinogenic substances, with more than 90% of cancers occurring in trachea and bronchus being reported to result from smoking. Lung cancer is classified into non-small cell carcinoma and small cell carcinoma according to microscopic cell types of cancer cells. Non-small cell lung cancer accounts for about 80% of total lung cancer and squamous cell carcinoma squamous cell carcinoma, adenocarcinoma, and large-cell carcinoma.
소세포 폐암은 전체 폐암의 약 20%를 차지하며 주로 기도(기관지나 세기관지)에서 처음 발병한다. 암종은 대개 기관의 표면이나 선을 따라 생성되어, 대부분(4/5) 폐 중앙부에 생기고, 나머지(1/5)는 말초에 생긴다. 전반적으로 악성도가 강해서 성장속도가 빠르고 림프계통이나 혈액순환을 통해 조기에 멀리 전이되는 경향이 있다. 이러한 폐암의 치료방법으로는 수술, 방사선 요법 및 항암화학요법이 사용되고 있으나, 비소세포 폐암의 경우 완전한 수술적 절제가 가능하였던 환자들의 경우에도 다수의 환자가 수술 후 재발하기 때문에 결국 1기에서 60~70%, 2기에서 30~50%, 3기에서 10~30%의 환자에서만 장기 생존이 가능하다. 전체적으로 보면 5년 생존율은 30% 밖에 안되며 10년 생존율은 15%에 불과하다. 이와 같이 불량한 치료 성적을 향상시키고자 많은 노력이 이루어지고 있는데, 수술을 전후하여 항암화학요법이나 방사선요법의 병용 등으로 일부에서 효과가 입증되었으나 여러 가지 부작용을 유발하며, 치료율도 여전히 불만족스러운 실정이다.Small cell lung cancer accounts for about 20% of all lung cancers, and it usually develops primarily in the airways (trachea or bronchus). Carcinomas are usually produced along the surface or line of an organ, most (4/5) in the middle of the lung, and the rest (1/5) in the periphery. Overall, malignancy is so rapid that it tends to grow at a rapid rate and to migrate away early through the lymphatic system or blood circulation. However, in the case of non-small cell lung cancer, even in patients who were able to undergo complete surgical resection, many patients recurred after surgery, Long-term survival is possible in only 70% of patients, 30-50% in stage 2, and 10-30% in stage 3. Overall, the 5-year survival rate is only 30% and the 10-year survival rate is only 15%. Although there have been a number of attempts to improve the outcome of such poor treatment, some have been proven effective in some cases, such as the combination of chemotherapy and radiotherapy before and after surgery, but these side effects are still present and the treatment rate is still unsatisfactory .
독성과 부작용이 적으면서 폐암에 대한 항암효과를 나타내는 천연물을 찾아내기 위하여 많은 연구가 진행되고 있으며, 특히, 비교적 인체에 안전한 한약재를 이용한 항암 치료약 및 항암 치료보조제 개발 연구가 활발하게 진행되고 있다.
Many researches have been conducted to find natural products exhibiting anticancer effects against lung cancer with few toxicity and side effects. In particular, studies on the development of anticancer drugs and anticancer drugs using relatively safe human medicines have been actively conducted.
본 발명의 목적은 약물의 효능을 높이고 부작용을 낮추는 효과를 달성할 수 있는 호흡기암 예방 또는 치료용 조성물을 제공하는 것이다.It is an object of the present invention to provide a composition for preventing or treating respiratory cancer which can achieve the effect of enhancing the efficacy of a drug and lowering side effects.
본 발명의 다른 목적은 상기 생약 성분을 유효성분으로 포함하는 호흡기암 예방 또는 개선용 건강기능식품을 제공하는 것이다.Another object of the present invention is to provide a health functional food for preventing or ameliorating respiratory cancer comprising the herbal medicine ingredient as an active ingredient.
상기와 같은 과제를 해결하기 위하여,In order to solve the above problems,
본 발명은 목향 및 단삼의 생약성분을 유효성분으로 포함하는 호흡기암 예방 또는 치료용 한방 조성물을 제공한다. The present invention provides a herbal composition for preventing or treating respiratory cancer, which contains a herbal medicine ingredient of moss and persimmon as an active ingredient.
본 발명에 있어서, 상기 조성물은 산양산삼 또는 현삼, 동충하초 및 장생도라지를 더 포함하는 것 일 수 있다.In the present invention, the composition may further comprise a ginseng root or ginseng, Cordyceps, and Jang Saeng Doraji.
본 발명에 있어서, 상기 조성물은 조성물 충중량을 기준으로 목향 1 내지 10 중량%, 단삼 1 내지 10 중량%를 포함하는 것 일 수 있다.In the present invention, the composition may contain 1 to 10% by weight of wheat straw and 1 to 10% by weight of rice straw, based on the weight of the composition.
본 발명에 있어서, 상기 조성물은 고본, 천마, 시호, 도인, 계지, 대황, 감초, 천궁, 진피, 택사, 황련, 황금, 복령, 작약, 백출, 황백, 치자, 반하, 조구등, 지실, 맥문동, 원지, 석창포, 창출, 감국, 방풍, 생강, 망초, 대조, 목단피, 지황, 박하, 산약, 저령, 하수오, 구자, 결명자, 독활, 두충, 백화사설초, 삼백초, 인진, 지모, 홍화, 황기, 석송자, 은행잎, 황정, 연자육, 용골, 지골피, 우슬, 숙지황, 흑임자, 백자인, 맥아, 파극천 및 해송으로 구성된 군에서 선택되는 하나 이상의 생약 성분을 추가로 포함하는 것 일 수 있다. The composition according to the present invention may be used in a variety of forms such as a tablet, a chewing gum, a citron, a dozen, a clam, a rhubarb, a licorice, a cinnabar, a dermis, Ginseng, ginseng, control, rhizome, rhubarb, peppermint, ginseng, ginseng, ginseng, guisha, killer, virginia, mulberry, , One or more herbal medicine ingredients selected from the group consisting of ginkgo leaf, hwangjeong, prawn, keel, coriander, persimmon, sorghum, black potato, white porcelain, malt,
본 발명에 있어서, 상기 조성물은 천연물 생약 처방을 위한 것일 수 있다.In the present invention, the composition may be for a natural product herbal medicine prescription.
본 발명에 있어서, 상기 조성물은 항암 공진단 제조를 위한 것일 수 있다.In the present invention, the composition may be for producing an anticancer resonant end.
또한, 상기 조성물이 경구흡수, 경피흡수, 점막흡수, 흡입, 좌훈, 비훈 또는 주사로 투여되는 것일 수 있다.Also, the composition may be administered by oral absorption, transdermal absorption, mucosal absorption, inhalation, dysphagia, salvage, or injection.
또한, 본 발명은 상기 생약 성분을 유효성분으로 포함하는 호흡기암 예방 또는 개선용 건강기능식품을 제공한다.
The present invention also provides a health functional food for preventing or ameliorating respiratory cancer comprising the herbal medicine ingredient as an active ingredient.
본 발명은 목향 및 단삼을 유효성분으로 하는 호흡기암 예방 또는 치료용 한방 조성물과, 상기 생약성분을 유효성분으로 포함하는 호흡기암 예방 또는 개선용 건강기능식품을 제공한다. 본 발명에 따른 조성물 및 건강기능식품은 목향 및 단삼의 생약성분을 함유함로써 호흡기암에 대한 항암효과가 우수하다. The present invention provides a herbal composition for prevention or treatment of respiratory cancer and an herbal composition containing the herbal medicine ingredient as an active ingredient, the herbal composition comprising sesame and persimmon extract as active ingredients, and a health functional food for preventing or ameliorating respiratory cancer. The composition and the health functional food according to the present invention contain a herbal medicine ingredient of moss and radish, and thus have excellent anticancer effect against respiratory cancer.
도 1은 목향 추출물의 폐암세포에 대한 세포독성실험결과를 나타내는 그래프이다.
도 2는 단삼 추출물의 폐암세포에 대한 세포독성실험결과를 나타내는 그래프이다.
도 3은 혼합 생약제 추출물의 폐암세포에 대한 세포독성실험결과를 나타내는 그래프이다.FIG. 1 is a graph showing the cytotoxicity test results on lung cancer cells of wort extract. FIG.
2 is a graph showing the results of cytotoxicity tests on lung cancer cells of the extract of Rana cv.
FIG. 3 is a graph showing cytotoxicity test results of lung cancer cells of mixed crude drug extract. FIG.
본 발명은 다양한 변환을 가할 수 있고 여러 가지 실시예를 가질 수 있는 바, 특정 실시예를 도면에 예시하고 상세한 설명에 상세하게 설명하고자 한다. 그러나, 이는 본 발명을 특정한 실시 형태에 대해 한정하려는 것이 아니며, 본 발명의 사상 및 기술 범위에 포함되는 모든 변환, 균등물 내지 대체물을 포함하는 것으로 이해되어야 한다. 본 발명을 설명함에 있어서 관련된 공지 기술에 대한 구체적인 설명이 본 발명의 요지를 흐릴 수 있다고 판단되는 경우 그 상세한 설명을 생략한다.BRIEF DESCRIPTION OF THE DRAWINGS The present invention is capable of various modifications and various embodiments, and specific embodiments are illustrated in the drawings and described in detail in the description. It is to be understood, however, that the invention is not to be limited to the specific embodiments, but includes all modifications, equivalents, and alternatives falling within the spirit and scope of the invention. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS Hereinafter, the present invention will be described in detail with reference to the accompanying drawings.
본 명세서에 사용된 "적용대상"은 질환 또는 질병 자체를 의미할 수 있으며, 질환 또는 질병을 가진 개인 또는 환자를 또한 의미할 수 있고, 바람직하게는 폐암 또는 폐암을 가진 환자를 의미하는 것으로 이해될 수 있다.As used herein, "subject of application" may mean a disease or a disease itself, and may also mean an individual or patient with a disease or condition, preferably a patient with lung cancer or lung cancer .
또한 "적용"한다는 의미는 상기 적용대상에 약제를 투입, 주입, 흡수시키는 것을 의미할 수 있으며, 약제가 약효를 나타내기 위해 직접 또는 간접적으로 상기 적용대상에 도달하는 것을 의미할 수 있다.In addition, the term "applied" may mean injecting, injecting, or absorbing a drug into the application target, and may mean that the drug directly or indirectly reaches the application target to exhibit the drug effect.
이하, 본 발명을 보다 상세하게 설명한다.Hereinafter, the present invention will be described in more detail.
본 발명은 목향 및 단삼의 생약성분을 유효성분으로 포함하는 호흡기암 예방 또는 치료용 한방 조성물을 제공한다.The present invention provides a herbal composition for preventing or treating respiratory cancer, which contains a herbal medicine ingredient of moss and persimmon as an active ingredient.
상기 목향(木香, Inula helenium)은 향기가 꿀과 같아서 밀향(蜜香)이라고도 한다. 또한 한 그루에 5개의 뿌리가 있고, 하나의 줄기에 5개의 가지가 있으며, 하나의 가지에 5개의 잎이 있고, 잎 사이마다 5개의 마디가 있어 오향(五香)이라고도 하였으며 그것을 태우면 온 천지에 향이 퍼진다고 하였다. 이 약은 특이한 냄새가 있고 맛은 맵고 쓰며 성질은 따뜻하다. The above-mentioned incense ( Inula helenium ) is also called honey aroma because the aroma is like honey. It also has five roots in one plant, five branches in one stem, five leaves in one branch, five nodes in each leaf, and it is also called ogyang (五 香). It is said to spread. This medicine has a peculiar smell, and the taste is spicy and the quality is warm.
목향은 복부가 차서 생기는 복통, 헛배 부른 증상, 구토, 설사에 사용하며 기를 잘 통하게 해 소화기의 만성 염증, 위통에 효과가 있고, 항균작용이 있어 이질과 고환염에 쓰이며, 약리작용으로 기관지와 소장 경련을 풀어주며 혈압강하작용, 항균작용 등이 보고되어 있다.It is used for abdominal pain, diarrhea, vomiting and diarrhea caused by abdomen. It is effective for chronic inflammation of stomach, stomach cramps, antimicrobial action, and is used for dysentery and testis inflammation. And blood pressure lowering action, antibacterial action, etc. have been reported.
또한, 상기 단삼(丹參)은 적삼(赤參)이라고도 불리며, 풍병(風病)을 치료하여 하지 무력감을 없애주므로 달리는 말을 쫓아갈 수 있게 한다하여 분마초(奔馬草) 라는 이름으로 불리기도 한다. In addition, the dansans is also called red ginseng, and it treats windmill disease (wind disease) and eliminates the feeling of helplessness, so it is called the name of ぬ 馬 草.
단삼은 혈액순환을 돕고, 어혈을 제거하며 사지관절 동통을 완화시켜, 부인의 생리불순, 생리통, 산후복통, 어혈성심복부통, 타박상 등을 치료한다. 고열로 인한 정신혼몽, 헛소리, 번조, 불면증, 피부발진, 심계항진 등을 치료한다. 약리작용은 관상동맥 확장, 콜레스테롤 강하, 혈압 강하, 간기능 활성화, 진정 항염, 항암, 항균작용이 보고되어 있다.Dansam helps blood circulation, removes eosinophils, alleviates pain in the extremities, treats menstrual irregularities, menstrual cramps, postpartum abdominal pain, abdominal fullness, and bruises. It treats mental confusion, bullshit, fury, insomnia, skin rash, palpitation, etc. due to high fever. Pharmacological actions have been reported for coronary artery dilatation, cholesterol depression, hypotension, liver function activation, sedative anti-inflammatory, anti-cancer, and antimicrobial effects.
상기 조성물은 산양산삼 또는 현삼, 동충하초 및 장생도라지를 더 포함하는 것일 수 있다.The composition may further comprise ginseng or ginseng, Cordyceps, and Jang Saeng Doraji.
상기 산양산삼은 장뇌삼, 장뇌, 장뇌산삼 또는 장로라고도 하며 인삼의 씨를 산에 뿌려 야생상태로 재배한 것이다.The above-mentioned ginseng is also called as ginseng, camphor, camphor, ginseng or elder, and the ginseng seed is sprayed on the mountains and grown in a wild state.
인삼(Panax ginseng)은 한방에서 강장, 강심, 강정, 진정약으로 사용되며 위장의 쇠약으로 오는 신진대사기능 저하, 위 무력감, 소화불량, 식욕부진 등에 처방한다. 인삼의 생리활성으로 노화억제, 동백경화 예방, 고지혈증 개선, 간 기능 개선, 항 산화작용, 항스트레스 작용, 면역력 증강, 뇌 기능 개선, 항암 효과 등이 다양하여 인체의 항상성을 유지하고 모든 병리 상태를 정상화 한다고 보고되어 있다. Ginseng (Panax ginseng) is used as a medicinal lotion, ginseng, gangjeong and soothing medicine in a herbal medicine. It is prescribing to the depression of the stomach, deterioration of metabolism, stomach weakness, indigestion and anorexia. It has various physiological activities such as inhibition of aging, prevention of camellia hardening, improvement of hyperlipidemia, improvement of liver function, antioxidant effect, anti-stress effect, immunity enhancement, improvement of brain function and anticancer effect. Normalization.
특히, 인삼의 진세노사이드(ginsenoside) 성분은 항암효과 이외에도 면역증강효과(ginsenoside Rg1/ Okamura N et al. Biol. Pharm. Bull. 17(2), 270(1994)), 항피로작용(ginsenoside Rg1/ Saito H et al. Japan J. Pharmacology, 24, 119(1974)), 유해자극 방어작용(ginsenoside Rg1/ Yoshimatsu H et al. Physiology and Behavior, 53(1), 1(1993)), 호르몬 분비 촉진작용 (ginsenoside Rd, Re/Hiai S et al. Chem Pharm. Bull. 31, 168(1983)), 단백질 합성 촉진작용 (ginsenoside Rb1/ Zhang J T et al. Acta Pharmaceutica Sinica 23(1), 12,(1988)) 등 다양한 약리 효과를 가지고 있는 것으로 알려져 있다.In particular, the ginsenoside component of ginseng has been shown to have anti-cancer effects as well as ginsenoside Rg1 / Okamura N et al. Biol. Pharm. Bull. 17 (2), 270 (1), 1 (1993)), stimulation of hormone secretion (Ginsenoside Rg1 / Yoshimatsu H et al. Physiology and Behavior, 53 (Ginsenoside Rd, Re / Hiai S et al., Chem Pharm Bull 31, 168 (1983)), ginsenoside Rb1 / Zhang JT et al. Acta Pharmaceutica Sinica 23 (1), 12 )) And has been known to have various pharmacological effects.
또한, 현삼(玄蔘)은 중대(重臺), 현대(玄臺), 귀장(鬼藏), 축마(逐馬)라고도 하며, 산지에서 자라는 식물로, 한방에서 뿌리를 현삼이라고 하며 해열제로 인후염, 종기 및 림프선염에 사용하며, 진세노사이드 중 항암효과가 있는 Rg3, Rh2등을 다량 함유하고 있는 것으로 알려져 있다.In addition, the ginseng (玄 蔘) is known as the middle stage, the modern (玄 臺), the 鬼 藏 (馬 藏) and the horse (馬 馬), the plant grows in the mountain, , Boils and lymphatic glands, and it is known that ginsenosides contain a large amount of Rg3 and Rh2, which have anticancer effects.
또한, 동충하초(Cordyceps militaris)는 겨울에는 곤충의 몸에 살면서 영양분을 흡수하여 곤충을 죽게 한 후 여름에는 죽은 곤충의 몸에서 버섯을 만든다는 뜻에서 붙여졌다. 동충하초는 인삼, 녹용과 더불어 예로부터 중국의 진구한 3대 보약 중의 하나로 알려져 오고 있다.In addition, Cordyceps militaris was inserted in the winter to live in the body of insects, absorb nutrients to kill the insects, and then to make mushrooms in the bodies of dead insects in the summer. Cordyceps, along with ginseng and antler, have long been known as one of the three most popular Chinese pills.
동충하초에는 약 7% 정도의 충초산이 들어있으며, 기를 돕고 폐를 윤활하게 하며, 출혈을 멎게 하고, 가래를 없애는 작용을 하며, 빈혈, 노년허약증 등에 치료효과가 좋은 것으로 알려져 있고, 예로부터 불로장생, 강정강장의 비약으로 애용되어 왔다. 중국 기록의 본초종신에는 폐를 보호하고 신장을 이롭게 하며, 가래를 삭이거나 결핵성 기침을 치료하는 데 쓰인다고 하였으며, 천연의약품대사전에는 달고 순하며 신장기능을 돕고 폐를 튼튼히 하며 강장, 정력보강, 진정, 빈혈 등에 효과가 있는 것으로 기록되어 있으며, 약리작용을 항목별로 보면, 결핵균, 폐렴구균, 저출혈성패혈증간균, 석고양소아포균, 탄저균, 비적간균 등에 억제 작용이 있는 항균작용; 강정강장, 효율적인 수면유도, 중추신경의 흥분을 억제, 항경련작용, 체온강하작용 등의 중추신경계통 작용; 감기, 만성기침, 천식, 결핵에의 효과, 기관지 확장작용, 가래제거, 호흡안정작용 등의 호흡계통작용; 폐기능 장애 치료, 심장박동 완만작용, 혈압강하작용, 콜레스테롤 저하작용, 산소결핍 내구작용, 항혈소판 취집작용 등의 심장 혈관계통작용; 자연 치유력, 염증 억제 등의 면역력 증강작용; 항암작용; 항노쇄작용; 만성 항피로작용; 마약중독 해독; 황달 치료에 효과적인 것으로 알려져 있는 것이다.Cordyceps contains about 7% of acetic acid. It helps to help the lungs, lubes the lungs, stops the bleeding, removes the sputum, and is known to have a good therapeutic effect on anemia and old age weakness. It has been used as a leap for Gangjeong. The main record of the Chinese record is that it is used to protect the lungs, to help the kidneys, to remove the sputum and to cure the tuberculous cough. The natural medicines are sweet and sweet, help the kidney function, strengthen the lungs, strengthen the tongue, Anemia, etc. Antimicrobial activity with inhibitory action on Mycobacterium tuberculosis, Streptococcus pneumoniae, Low hemorrhagic septicemia bacillus, Gypsophila aphos, Bacillus anthracis, and non-bacillus; Central nervous system effects such as gangjeong tang, effective sleep induction, suppression of central nervous excitement, anticonvulsive action, body temperature depression; Respiratory system effects such as cold, chronic cough, asthma, effects on tuberculosis, bronchodilation, removal of sputum, respiratory stabilization; Cardiovascular system effects such as pulmonary dysfunction treatment, heart rhythm gang action, hypotensive action, cholesterol lowering action, oxygen deprivation durability, anti-platelet aggregation action; Natural healing power, immunity enhancement such as inflammation suppression; Antitumor activity; Antifoaming action; Chronic antipyretic action; Drug addiction detoxification; It is known to be effective in treating jaundice.
또한, 장생도라지(Platycodon grandiflorum)는 20년 근 이상의 도라지를 말하는 것으로, 그 동안 도라지의 다양한 약리작용에도 불구하고, 장기간 재배가 어려웠으나, 최근 20년 근 이상의 도라지인 장생도라지를 재배할 수 있는 기술이 개발되어 다량생산이 가능해 졌다. 이러한 장생도라지는 2 ~ 4년 근의 일반 도라지에 비해 약리작용과 생리활성효능이 우수한 것이다.Platycodon grandiflorum refers to platycodon of more than 20 years old. Despite various pharmacological actions of platycodon, it has been difficult to cultivate for a long time. However, the technology to cultivate long platycodon, Has been developed and mass production has become possible. Such Jang Saeng Doraji is superior in pharmacological action and physiological activity effect to general Doraji of 2 ~ 4 years old muscle.
도라지(길경 Platycodon grandiflorum A. DC)는 도라지과(Campanulaceae)의 식물로 주근이 10 ~ 15 cm 내외이고 지름은 1 ~ 3cm 이며 윗부분에는 불규칙한 줄기 자리가 있고 회갈 ~ 유백색이며 세로 주름이 깊고, 가로로는 파목(皮目)과 주름이 있다. 질은 단단하나 비섬유성이어서 파절이 쉽고 약간의 냄새가 나며 맛은 아리다 (육창수 등, 현대 생약학, 서울, 창사, 460-461, 1993). 이러한 도라지의 주요 약리성분은 트리테르펜계 사포닌(platycodin A, C, D, D2, D3)으로서 뿌리의 약 3 %를 차지하며, 이 약리성분은 동물실험을 통하여 진해, 거담작용, 중추신경억제작용(진정, 진통, 해열효과), 급만성 염증에 대한 항염증작용, 항 궤양 및 위액분비억제작용, 혈관을 확장하여 혈압을 낮추는 항 콜린작용, 혈당강하작용, 콜레스테롤 대사 개선 작용 등이 있는 것으로 밝혀져 있는 것이다.Platycodon grandiflorum A. DC is a plant of the Campanulaceae, about 10 to 15 cm in diameter, 1 to 3 cm in diameter, with irregular stems on the upper part, gray to milky white, with deep vertical wrinkles, There are twigs and wrinkles. The vagina is hard, non-fibrous, easy to break, slightly odorless, and tastes good (Jang Chang Soo et al., Hyundai Genetics, Seoul, Changsha, 460-461, 1993). The main pharmacological component of the bellflower is tritiated with saponins (platycodin A, C, D, D2 and D3), which account for about 3% of the roots. (Anti-inflammatory effect against acute chronic inflammation, anti-ulcer and gastric secretion suppressing action, anti-cholinergic action to lower blood pressure by expanding blood vessels, hypoglycemic action, and improvement of cholesterol metabolism) It is.
상기 조성물은 목향과 단삼을 1: 0.5 내지 1.5의 중량비로 포함할 수 있다. 조성물 총중량을 기준으로 목향 1 내지 10 중량%, 단삼 1 내지 10 중량%를 포함하는 것이 바람직하다. 더욱 바람직하게는 목향 3 내지 8 중량% 및 단삼 3 내지 8 중량%를 포함할 수 있으며, The composition may contain a mixture of wheat germ and spinach at a weight ratio of 1: 0.5 to 1.5. Based on the total weight of the composition, 1 to 10% by weight of corn, 1 to 10% by weight of corn germ. More preferably from 3 to 8% by weight of cornflower and from 3 to 8% by weight of cornflower,
또한, 상기 조성물은 산양산삼, 동충하초 및 장생도라지를 더 포함할 수 있으며, 이들의 중량비는 순서대로 1: 0.5 내지 1.5: 0.5 내지 1.5 일 수 있다. 조성물 충중량을 기준으로 산양산삼 또는 현삼 20 내지 40중량%, 동충하초 20 내지 40 중량% 및 장생도라지 20 내지 40중량% 를 포함하는 것이 바람직하다. 더 바람직하게는 산양산삼 또는 현삼, 동충하초, 장생도라지를 각각 25 내지 35중량% 포함할 수 있다. In addition, the composition may further comprise ginseng root ginseng, Chinese caterpillar fungus and Jang Saeng Doraji, and the weight ratio thereof may be in the order of 1: 0.5 to 1.5: 0.5 to 1.5. Based on the weight of the composition, 20 to 40% by weight of goat or ginseng, 20 to 40% by weight of cordyceps, and 20 to 40% by weight of Jang Saeng Doraji. More preferably 25 to 35% by weight of the ginseng root ginseng or the ginseng root, Cordyceps sinensis, and Jang Saeng Doraji.
또한, 상기 조성물은 고본, 천마, 시호, 도인, 계지, 대황, 감초, 천궁, 진피, 택사, 황련, 황금, 복령, 작약, 백출, 황백, 치자, 반하, 조구등, 지실, 맥문동, 원지, 석창포, 창출, 감국, 방풍, 생강, 망초, 대조, 목단피, 지황, 박하, 산약, 저령, 하수오, 구자, 결명자, 독활, 두충, 백화사설초, 삼백초, 인진, 지모, 홍화, 황기, 석송자, 은행잎, 황정, 연자육, 용골, 지골피, 우슬, 숙지황, 흑임자, 백자인, 맥아, 파극천 및 해송으로 구성된 군에서 선택되는 하나 이상의 생약 성분을 추가로 포함하는 것일 수 있다. In addition, the composition may be used in a variety of compositions including, but not limited to, gibbons, rhododendrons, rhododendrons, rhododendrons, rhododendrons, rhubarb, licorice, , Ginger, ginseng, control, rhizome, rhubarb, peppermint, mackerel, ginseng, goose, gojae, lemonade, And may further comprise at least one herbal medicine ingredient selected from the group consisting of Hwangjeong, prawn, keel, coriander, oyster, sorghum, black potato, white porcelain, malt,
또한, 상기 조성물은 천연물 생약 처방을 위한 것일 수 있으며, 항암 공진단 제조를 위한 것일 수 있다.In addition, the composition may be one for a natural product herbal medicine prescription, and may be for producing an anticancer cavity.
또한, 상기 조성물은 경구흡수, 경피흡수, 점막흡수, 흡입, 좌훈, 비훈 또는 주사로 투여되는 것일 수 있다. In addition, the composition may be administered by oral absorption, transdermal absorption, mucosal absorption, inhalation, stool, bupivacaine or injection.
본 발명은 또한, 상기 생약 성분을 유효성분으로 포함하는 호흡기암 예방 또는 개선용 건강기능식품을 제공한다
The present invention also provides a health functional food for preventing or ameliorating respiratory cancer comprising the herbal medicine ingredient as an active ingredient
이하, 본 발명의 이해를 돕기 위하여 실시예를 제시하나, 하기 실시예는 본 발명을 예시하는 것일 뿐 본 발명의 범주 및 기술사상 범위 내에서 다양한 변경 및 수정이 가능함은 본 기술분야에서 통상의 지식을 가진 자에게 있어서 명백한 것이며, 이러한 변형 및 수정이 첨부된 특허청구범위에 속하는 것도 당연한 것이다.
It is to be understood that both the foregoing general description and the following detailed description are exemplary and explanatory and are intended to be illustrative of the present invention and the scope of the invention as defined by the appended claims. It will be obvious to those skilled in the art that these modifications and variations are included in the scope of the appended claims.
제조예 1 : 목향 및 단삼 추출물의 제조 Production Example 1: Preparation of Wort and Radix extract
호흡기암 예방 또는 치료용 생약성분인 목향 및 단삼을 하기와 같은 방법으로 생약 추출물을 제조하였다.Herbal medicine extracts were prepared by the following methods, which were herbal ingredients for preventing or treating respiratory cancer.
목향을 흐르는 물에 깨끗이 세척한 후 증류수와 배합하여 약 2시간 가량 전탕한 후 찌꺼기는 따로 분리하고, 전탕액을 무균실에 있는 증류 추출기에 넣고 전탕하여 목향 100g으로 1000ml의 추출액을 얻었다. 얻어진 추출액을 0.45 ㎛, 0.2 ㎛ 여과지로 2회 여과하여 추출물을 준비하였다.After washing thoroughly in flowing water, the mixture was mixed with distilled water for about 2 hours, and the residue was separated. The solution was transferred to a distillation extractor in a sterile room and transferred to obtain 1000 ml of extracts. The obtained extract was filtered twice with 0.45 mu m and 0.2 mu m filter paper to prepare an extract.
단삼도 목향과 같은 방법으로 준비하였다.
Danshams were also prepared in the same way as those of the field.
제조예 2 : 혼합 생약제 추출물의 제조Production Example 2: Preparation of mixed crude drug extract
목향 및 단삼을 유효성분으로 하는 호흡기암 예방 또는 치료용 한방 조성물을 하기 표 1과 같은 구성으로 제조하였다.
The present invention relates to a herbal composition for preventing or treating respiratory cancer,
실시예 1 : 폐암세포주 A549를 이용한 추출물의 세포독성실험Example 1: Cytotoxicity test of extracts using lung cancer cell line A549
상기 제조예 1 및 2에서 준비한 목향 추출물, 단삼 추출물 및 혼합 생약제 추출물의 폐암세포에 대한 세포 독성을 알아보기 위하여 하기와 같이 실험하였다. To examine the cytotoxicity of the extracts of Lycoris chejuensis, Radix Salviae Radix Extract and Mixed Herbal Extracts prepared in Preparation Examples 1 and 2 to lung cancer cells, the following experiment was conducted.
인간 폐암세포 A549(Human lung carcinoma cell line) 세포는 10% FBS, 100 units/ml 페니실린, 100 units/ml 스트렙토마이신, 0.25 ㎍/ml 암포테리신 B 를 첨가한 RPMI 1640 배지를 사용하여 37℃, 5% CO2 분위기의 배양기에서 배양하였다.Human lung carcinoma cell line A549 cells were cultured in RPMI 1640 medium supplemented with 10% FBS, 100 units / ml penicillin, 100 units / ml streptomycin and 0.25 / / ml amphotericin B at 37 ° C, And cultured in a 5% CO 2 incubator.
상기에서 배양된 A549 세포를 24-well 플레이트에 2 x 104 cell/well의 밀도로 세포를 분주하고, 상기 제조예 1 및 2 에서 준비한 목향 추출물, 단삼 추출물 및 혼합 생약제 추출물을 각각 0 ㎍/ml, 50 ㎍/ml, 100 ㎍/ml, 125 ㎍/ml, 250 ㎍/ml 및 500 ㎍/ml의 농도로 24시간 동안 37℃, 5% CO2 분위기의 배양기에서 세포를 배양한 후, 배지에 MTT 용액을 0.5 mg/mL 농도로 처리하고 3시간 반응시킨 후, 배지를 제거하고, 실온에서 건조 후 DMSO로 용해시켜 ELISA reader를 이용하여 570nm 파장에서 흡광도를 측정하였다. 상기 실험결과는 도 1 내지 도 3에 나타내었다.The A549 cells cultured as described above were seeded on a 24-well plate at a density of 2 x 10 4 cells / well. The extracts of Wakamatsu, Panax ginseng and Mixed herbal preparations prepared in Preparation Examples 1 and 2 were added at 0 ug / ml The cells were cultured in an incubator at 37 ° C in a 5% CO 2 atmosphere for 24 hours at a concentration of 50 μg / ml, 100 μg / ml, 125 μg / ml, 250 μg / ml and 500 μg / The MTT solution was treated at a concentration of 0.5 mg / mL and reacted for 3 hours. The medium was then removed, dried at room temperature, dissolved in DMSO, and absorbance measured at 570 nm using an ELISA reader. The results of the experiment are shown in Figs.
상기 실험 결과 목향 추출물의 경우 약 150 ㎍/ml 에서 유의적인 활성을 보여 주는 것을 도 1을 통하여 확인 할 수 있었으며, 단삼의 경우 약 125 ㎍/ml 에서 유의적인 활성을 보여주는 것을 도 2를 통하여 확인 할 수 있었다. 뿐만 아니라, 혼합 생약제 추출물의 경우 약 200 ㎍/ml에서 유의적 활성을 보이는 것을 도 3에서 확인 할 수 있었다. As a result of the above test, it was confirmed that the extract of Wisteria extract showed a significant activity at about 150 ㎍ / ml through FIG. 1, and a significant activity at about 125 ㎍ / ml in the case of Dansamp I could. In addition, it was confirmed in FIG. 3 that the mixed herb extract had significant activity at about 200 / / ml.
상기와 같은 결과에서 목향 및 단삼이 폐암 세포 독성을 나타내는 것을 확인 할 수 있었으며, 목향과 단삼뿐만 아니라 산양산삼, 동충하초 및 장생도라지를 포함하는 혼합 생약제 추출물 또한 폐암 세포 독성을 나타내는 것을 확인 할 수 있었다.
From the above results, it was confirmed that the extracts of Lycopersicon esculentum and Candida were shown to be cytotoxic to lung cancer cells, and the extracts of mixed herbicidal products including Lycopersicon esculentum, Cordyceps,
Claims (8)
목향 1 내지 10중량%, 단삼 0.5 내지 15중량%, 산양산삼 20 내지 40중량%, 동충하초 20 내지 40중량% 및 장생도라지 20 내지 40중량%를 포함하는, 호흡기암 예방 또는 치료용 한방 조성물.The present invention relates to a composition comprising, as an active ingredient, a herbal medicine ingredient of Korean cabbage, Korean cabbage, Chinese cabbage, Chinese cabbage,
A herbal composition for preventing or treating respiratory tract cancer, comprising 1 to 10% by weight of corn, 0.5 to 15% by weight of ginseng, 20 to 40% by weight of goat ginseng, 20 to 40% by weight of cordyceps, and 20 to 40% by weight of Jang Saeng Doraji.
상기 조성물은 고본, 천마, 시호, 도인, 계지, 대황, 감초, 천궁, 진피, 택사, 황련, 황금, 복령, 작약, 백출, 황백, 치자, 반하, 조구등, 지실, 맥문동, 원지, 석창포, 창출, 감국, 방풍, 생강, 망초, 대조, 목단피, 지황, 박하, 산약, 저령, 하수오, 구자, 결명자, 독활, 두충, 백화사설초, 삼백초, 인진, 지모, 홍화, 황기, 석송자, 은행잎, 황정, 연자육, 용골, 지골피, 우슬, 숙지황, 흑임자, 백자인, 맥아, 파극천 및 해송으로 구성된 군에서 선택되는 하나 이상의 생약 성분을 추가로 포함하는 것을 특징으로 하는 호흡기암 예방 또는 치료용 한방 조성물.The method according to claim 1,
The composition may be selected from the group consisting of Chinese cabbage, Chinese cabbage, Chinese cabbage, Chinese cabbage, Chinese cabbage, Chinese cabbage, licorice, Chinese cabbage, dermis, taxa, Chinese cabbage, golden cabbage, , Ginger, ginger, ginseng, control, rhododendron, rhubarb, mint, mildew, ginseng, drowning, guisha, Wherein the composition further comprises at least one herbal medicine ingredient selected from the group consisting of sweet potato, prawn meat, keel, coriander, wax, sorghum, black potato, white porcelain, malt,
목향 1 내지 10중량%, 단삼 0.5 내지 15중량%, 산양산삼 20 내지 40중량%, 동충하초 20 내지 40중량% 및 장생도라지 20 내지 40중량%를 포함하는, 호흡기암 예방 또는 개선용 건강기능식품.The present invention relates to a composition comprising, as an active ingredient, a herbal medicine ingredient of Korean cabbage, Korean cabbage, Chinese cabbage, Chinese cabbage,
A health functional food for preventing or ameliorating respiratory cancer, comprising 1 to 10% by weight of tea seeds, 0.5 to 15% by weight of ginseng, 20 to 40% by weight of goat ginseng, 20 to 40% by weight of cordyceps, and 20 to 40% by weight of Jang Saeng Doraji.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020150135248A KR101951203B1 (en) | 2015-09-24 | 2015-09-24 | A composition for preventing or treating respiratory cancers comprising herbal ingredients |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020150135248A KR101951203B1 (en) | 2015-09-24 | 2015-09-24 | A composition for preventing or treating respiratory cancers comprising herbal ingredients |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20150115709A KR20150115709A (en) | 2015-10-14 |
KR101951203B1 true KR101951203B1 (en) | 2019-02-25 |
Family
ID=54357758
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020150135248A Expired - Fee Related KR101951203B1 (en) | 2015-09-24 | 2015-09-24 | A composition for preventing or treating respiratory cancers comprising herbal ingredients |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101951203B1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102258590B1 (en) * | 2020-01-30 | 2021-06-02 | 주식회사 엠제이블루밍알앤디 | Composition Comprising Extract of Saccharina japonica and Herb Medicines for Improvement of Respiratory Disease |
WO2022065970A3 (en) * | 2020-09-28 | 2022-05-19 | 한국한의학연구원 | Composition comprising natural product mixed extract for prevention or treatment of coronavirus infection |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101941368B1 (en) * | 2017-06-21 | 2019-01-22 | 경희대학교 산학협력단 | Composition for preventing or treating cancer comprising Salvia militiorrhiza |
KR102128457B1 (en) * | 2018-04-06 | 2020-06-30 | 농업회사법인 주식회사 한반도 | Food composition for improvement of respiratory function |
CN108210592B (en) * | 2018-05-22 | 2018-09-04 | 上海国宝企业发展中心 | Chinese medicine composition for treating breathing problem |
KR20230110893A (en) | 2022-01-17 | 2023-07-25 | 경상국립대학교산학협력단 | Composition for preventing or treating lung diseases caused by ultrafine dust containing Eucommia ulmoides’s leaves fraction as an active ingredient |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005044182A2 (en) * | 2003-09-08 | 2005-05-19 | Genyous Biomed International Inc. | Compositions of botanical extracts for cancer therapy |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101951194B1 (en) * | 2015-04-30 | 2019-02-25 | 주식회사 씨엔에이치코퍼레이션 | A composition for preventing or treating gastrointestinal cancer comprising herbal ingredients |
-
2015
- 2015-09-24 KR KR1020150135248A patent/KR101951203B1/en not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005044182A2 (en) * | 2003-09-08 | 2005-05-19 | Genyous Biomed International Inc. | Compositions of botanical extracts for cancer therapy |
Non-Patent Citations (1)
Title |
---|
대한한방내과학회지. 2015. 제36권제1호, pp.58-68.* |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102258590B1 (en) * | 2020-01-30 | 2021-06-02 | 주식회사 엠제이블루밍알앤디 | Composition Comprising Extract of Saccharina japonica and Herb Medicines for Improvement of Respiratory Disease |
WO2022065970A3 (en) * | 2020-09-28 | 2022-05-19 | 한국한의학연구원 | Composition comprising natural product mixed extract for prevention or treatment of coronavirus infection |
Also Published As
Publication number | Publication date |
---|---|
KR20150115709A (en) | 2015-10-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101951203B1 (en) | A composition for preventing or treating respiratory cancers comprising herbal ingredients | |
KR20180037693A (en) | A food composition for preventing and improving lung diseases | |
CN101228968B (en) | Cigarette additive decreasing smoke gas harm | |
CN103564647A (en) | Preparation method of traditional Chinese medicine spices for tobaccos | |
CN104306659B (en) | A kind of Chinese medicine composition for treating diabetes B | |
CN108174945B (en) | Throat clearing food for smokers and preparation method thereof | |
CN108523121A (en) | A kind of functional food and preparation method thereof of anti-haze clearing lung-heat | |
KR101999675B1 (en) | Herbal composition for the prevention and treatment of coronary heart disease | |
CN110063977B (en) | Radix codonopsis and sea buckthorn composite electuary and application thereof | |
CN104547134A (en) | Medicine for treating burns | |
CN108686058A (en) | Seven apertures rhinitis-treating spray and preparation method thereof | |
CN108057115A (en) | A kind of composition for treating inflammation of upper respiratory tract infection and preparation method thereof | |
KR101435610B1 (en) | Allergic rhinitis herbal extract containing a method for preparing a pharmaceutical composition for improving | |
KR20170082957A (en) | Medicine for treating nasal obstruction and cough | |
CN105194023A (en) | High-grade buccal tablet capable of assisting in giving up smoking | |
KR100885480B1 (en) | Herbal whitening composition and preparation method thereof | |
CN104666999A (en) | Traditional Chinese medicine formula capable of reducing blood pressure | |
CN110237201A (en) | A kind of drug for treating chronic pulmonary aspergilosis | |
KR102590151B1 (en) | Pharmaceutical composition for preventing or treating of pancreatic cancer comprising medicinal herb complex extract | |
KR20200087573A (en) | Composition for preventing and treating of neuropathic pain containing nypa fruticans wurmb extract | |
KR20190076103A (en) | A Pharmaceutical composition comprising mixed herbal extract for preventing or treating lung cancer | |
CN112294915B (en) | Pharmaceutical composition for treating emphysema and preparation method thereof | |
CN109568496B (en) | A kind of detection method of traditional Chinese medicine composition for treating diabetes | |
KR102771025B1 (en) | Food composition for preventing and improving osteoporosis comprising fermented eleutherococcus senticosus | |
CN109106842B (en) | A medicine for stopping smoking and its preparation method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
G15R | Request for early publication | ||
PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20150924 |
|
PG1501 | Laying open of application |
Comment text: Request for Early Opening Patent event code: PG15011R01I Patent event date: 20150924 |
|
A201 | Request for examination | ||
A302 | Request for accelerated examination | ||
PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 20180627 Comment text: Request for Examination of Application Patent event code: PA02011R01I Patent event date: 20150924 Comment text: Patent Application |
|
PA0302 | Request for accelerated examination |
Patent event date: 20180627 Patent event code: PA03022R01D Comment text: Request for Accelerated Examination Patent event date: 20150924 Patent event code: PA03021R01I Comment text: Patent Application |
|
E902 | Notification of reason for refusal | ||
PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20180907 Patent event code: PE09021S01D |
|
E701 | Decision to grant or registration of patent right | ||
PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20190131 |
|
GRNT | Written decision to grant | ||
PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20190218 Patent event code: PR07011E01D |
|
PR1002 | Payment of registration fee |
Payment date: 20190219 End annual number: 3 Start annual number: 1 |
|
PG1601 | Publication of registration | ||
PR1001 | Payment of annual fee |
Payment date: 20220208 Start annual number: 4 End annual number: 4 |
|
PR1001 | Payment of annual fee |
Payment date: 20230118 Start annual number: 5 End annual number: 5 |
|
PC1903 | Unpaid annual fee |
Termination category: Default of registration fee Termination date: 20241201 |